Loren Data Corp.

'

 
 

COMMERCE BUSINESS DAILY ISSUE OF MAY 9,1996 PSA#1591

Centers for Disease Control and Prevention (CDC), Procurement & Grants Office, 255 East Paces Ferry Road, N.E., Room No. 405 Atlanta, Georgia 30305

B -- COMPREHENSIVE LINKED DATA COLLECTION OF MEDICAL EVENTS AND IMMUNIZATION (VACCINE SAFETY AND DEVELOPMENT DATA-LINK) SOL 200-96-0525(P) DUE 071296 POC Contact Susan E. Brandel, Contract Specialist at (404)842-6635 The Centers for Disease Control contemplates awarding a contract evaluate the safety, immunogenicity, and efficacy of vaccines recommended or intended for routine human use. The purpose of the study is to provide better scientific data to assess the potential risks, costs, and benefits of vaccination for policy purposes. THE MINIMAL CRITERIA WHICH MUST BE MET BEFORE A PROPOSAL WILL BE ACCEPTED FOR REVIEW INCLUDE SUBMISSION OF EVIDENCE DEMONSTRATING THAT: 1) the study population has greater than or equal to 3000 births annually; 2) a functional automated vaccination recording system for the study population; 3) an unique identifying number for each member of the study population has been assigned that permits linkage of automated vaccination records with automated and nonautomated medical records; 4) automated vaccination and medical records which have been evaluated for accuracy and completeness (methods and results must be provided); and 5) proof of easy access to medical records for validation purposes. The scheduled issue date for the RFP is approximately May 17, 1996. No telephone requests will be accepted; only written requests for this solicitation will be honored. Requests for copies of the solicitation may be transmitted by facsimile to (404) 842-6896. Requests should cite RFP No. 200-96-0525(P) and clearly state the address where a copy of the RFP should be sent. All responsible sources that meet the above requirements may submit a proposal which shall be considered by the Agency. (0128)

Loren Data Corp. http://www.ld.com (SYN# 0015 19960508\B-0001.SOL)


B - Special Studies and Analyses - Not R&D Index Page